To compare the effects of two drugs in the management of abnormal uterine bleeding
Not Applicable
- Conditions
- Health Condition 1: N938- Other specified abnormal uterine and vaginal bleeding
- Registration Number
- CTRI/2024/07/070066
- Lead Sponsor
- Government Medical College and Hospital Sector Chandigarh India Pincode
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women presenting to Gynaecological OPD with Abnormal Uterine Bleeding related to structural causes of the uterus, uterine fibroids and adenomyosis
Exclusion Criteria
1. Women with bulky fibroids presenting with pressure symptoms who are not fit for medical management.
2. Submucosal fibroid type 0 and type 1.
3. Endometrial polyp, endometrial hyperplasia or malignancy.
4. Complex adnexal mass.
5. Acute AUB.
6. Abnormal renal or hepatic function tests.
7. Coagulopathy.
8. History of breast or genital malignancy.
9. Smoking.
10. Thromboembolic disease.
11. Diabetes, hypertension, migraine or epilepsy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in amount and duration of menstrual blood loss by assessing pattern of periods through PBAC (Pictorial blood assessment charts) score.Timepoint: At the end of 2 months and 4 months after the start of treatment.
- Secondary Outcome Measures
Name Time Method 1. Change in pain score after medication based on NRS (Numerical pain rating score). <br/ ><br>2. Patient satisfaction with treatment using TSQM (Treatment satisfaction questionnaire for medication).Timepoint: At the end of 2 months and 4 months after the start of treatment.